Cargando…
Motions around conserved helical weak spots facilitate GPCR activation
G protein‐coupled receptors (GPCRs) participate in most physiological processes and are important drug targets in many therapeutic areas. Recently, many GPCR X‐ray structures became available, facilitating detailed studies of their sequence‐structure‐mobility‐function relations. We show that the fun...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290982/ https://www.ncbi.nlm.nih.gov/pubmed/34272892 http://dx.doi.org/10.1002/prot.26179 |
_version_ | 1784749035560632320 |
---|---|
author | Bibbe, Janne M. Vriend, Gert |
author_facet | Bibbe, Janne M. Vriend, Gert |
author_sort | Bibbe, Janne M. |
collection | PubMed |
description | G protein‐coupled receptors (GPCRs) participate in most physiological processes and are important drug targets in many therapeutic areas. Recently, many GPCR X‐ray structures became available, facilitating detailed studies of their sequence‐structure‐mobility‐function relations. We show that the functional role of many conserved GPCR sequence motifs is to create weak spots in the transmembrane helices that provide the structural plasticity necessary for ligand binding and signaling. Different receptor families use different conserved sequence motifs to obtain similar helix irregularities that allow for the same motions upon GPCR activation. These conserved motions come together to facilitate the timely release of the conserved sodium ion to the cytosol. Most GPCR crystal structures could be determined only after stabilization of the transmembrane helices by mutations that remove weak spots. These mutations often lead to diminished binding of agonists, but not antagonists, which logically agrees with the fact that large helix rearrangements occur only upon agonist binding. Upon activation, six of the seven TM helices in GPCRs undergo helix motions and/or deformations facilitated by weak spots in these helices. The location of these weak spots is much more conserved than the sequence motifs that cause them. Knowledge about these weak spots helps understand the activation process of GPCRs and thus helps design medicines. |
format | Online Article Text |
id | pubmed-9290982 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92909822022-07-20 Motions around conserved helical weak spots facilitate GPCR activation Bibbe, Janne M. Vriend, Gert Proteins Research Articles G protein‐coupled receptors (GPCRs) participate in most physiological processes and are important drug targets in many therapeutic areas. Recently, many GPCR X‐ray structures became available, facilitating detailed studies of their sequence‐structure‐mobility‐function relations. We show that the functional role of many conserved GPCR sequence motifs is to create weak spots in the transmembrane helices that provide the structural plasticity necessary for ligand binding and signaling. Different receptor families use different conserved sequence motifs to obtain similar helix irregularities that allow for the same motions upon GPCR activation. These conserved motions come together to facilitate the timely release of the conserved sodium ion to the cytosol. Most GPCR crystal structures could be determined only after stabilization of the transmembrane helices by mutations that remove weak spots. These mutations often lead to diminished binding of agonists, but not antagonists, which logically agrees with the fact that large helix rearrangements occur only upon agonist binding. Upon activation, six of the seven TM helices in GPCRs undergo helix motions and/or deformations facilitated by weak spots in these helices. The location of these weak spots is much more conserved than the sequence motifs that cause them. Knowledge about these weak spots helps understand the activation process of GPCRs and thus helps design medicines. John Wiley & Sons, Inc. 2021-07-26 2021-11 /pmc/articles/PMC9290982/ /pubmed/34272892 http://dx.doi.org/10.1002/prot.26179 Text en © 2021 The Authors. Proteins: Structure, Function, and Bioinformatics published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Bibbe, Janne M. Vriend, Gert Motions around conserved helical weak spots facilitate GPCR activation |
title | Motions around conserved helical weak spots facilitate GPCR activation |
title_full | Motions around conserved helical weak spots facilitate GPCR activation |
title_fullStr | Motions around conserved helical weak spots facilitate GPCR activation |
title_full_unstemmed | Motions around conserved helical weak spots facilitate GPCR activation |
title_short | Motions around conserved helical weak spots facilitate GPCR activation |
title_sort | motions around conserved helical weak spots facilitate gpcr activation |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290982/ https://www.ncbi.nlm.nih.gov/pubmed/34272892 http://dx.doi.org/10.1002/prot.26179 |
work_keys_str_mv | AT bibbejannem motionsaroundconservedhelicalweakspotsfacilitategpcractivation AT vriendgert motionsaroundconservedhelicalweakspotsfacilitategpcractivation |